Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

Historical Holders from Q1 2024 to Q3 2025

Symbol
PCSA on Nasdaq
CUSIP
74275C304
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
55.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.78M
Holdings value
$342K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
13
Number of buys
10
Number of sells
-8
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chiliz Group Ltd. 10.9% $984K 5.47M Chiliz Group Ltd. Aug 5, 2025
CVI Investments, Inc. 9% -9% $960K $102K 5M +11.8% CVI Investments, Inc. Sep 30, 2025
INTRACOASTAL CAPITAL, LLC 9.99% 0% $596K -$22.8K 2.91M -3.68% Mitchell P. Kopin Jun 30, 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $555K $434K 2.64M +357% Armistice Capital, LLC Jun 30, 2025
3i, LP 4.9% $387K 1.68M 3i, LP Jun 17, 2025

Institutional Holders of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.78M $342K +$268K $0.19 13
2025 Q2 373K $75.9K +$30.2K $0.21 12
2025 Q1 171K $63.2K +$10.4K $0.37 9
2024 Q4 98.9K $87.5K +$44.2K $0.88 8
2024 Q3 48.6K $66.5K +$4.75K $1.37 8
2024 Q2 45K $101K -$147K $2.24 8
2024 Q1 106K $251K +$251K $2.37 9